By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Taiwan Liposome Company (TLC) 

2F, 3 Yuanqu Street

Nankang  Taipei  115  Taiwan
Phone: 886-2-2655-7377 Fax: 886-2-2655-7366


SEARCH JOBS

Taiwan Liposome Company (TLC) is a biopharmaceutical company focused on the research, development and commercialization of innovative pharmaceutical products based on its proprietary drug delivery technologies. Our strengths lie in lipid-based formulation and scale-up for parenteral drugs using micelles and nanoparticles to optimize the pharmacokinetics of drugs for better efficacy and lower toxicity, and thus prolong the product lifecycle of branded drugs.

YEAR FOUNDED:

1997

LEADERSHIP:

Founder and CEO: Keelung Hong

CFO: Nicole Lin

JOBS:

Please click here for TLC job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

FOLLOW TLC:



Key Statistics


Email: info@tlcbio.com
Ownership: Private

Web Site: Taiwan Liposome Company (TLC)
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
Taiwan Liposome Company (TLC) Release: TLC178 Granted Orphan Drug Designation By U.S. FDA For The Treatment Of Cutaneous T-cell Lymphoma (CTCL) 10/19/2016 10:14:57 AM
Taiwan's Taiwan Liposome Company (TLC) Approved To Begin U.S. Clinical Trials Of Cancer Drug 10/4/2016 8:57:55 AM
SciClone Pharmaceuticals, Inc. (SCLN) and Taiwan Liposome Company Enter Into a Licensing Agreement for ProFlow®, a Novel Treatment for Peripheral Arterial Disease for the China Market 6/25/2013 9:50:10 AM
Taiwan Liposome Company's Liver Cancer Drug Put on Fast Track in China 3/19/2013 10:37:30 AM
Aptuit Consulting, Inc. and Taiwan Liposome Company Collaborate to Complete all IND Enabling Work and IND Submission for Novel Anti-Cancer Treatment in 12 Months 6/25/2008 10:32:51 AM
SRI International To Conduct Preclinical Studies Of Cancer Drug For Taiwan Liposome Company 10/3/2006 10:48:22 AM
//-->